Complications of using OKT3 for induction of immunosuppression in recipients of kidneys from nonheart beating donors.
Kehinde
E O
EO
Department of Surgery, Leicester General Hospital, United Kingdom.
Veitch
P S
PS
Scriven
S D
SD
Varty
K
K
Morgan
J D
JD
Furness
P
P
Horsburgh
T
T
Feehally
J
J
Bell
P R
PR
D000328:Adult; D000368:Aged; D001706:Biopsy; D004334:Drug Administration Schedule; D006323:Heart Arrest; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D007684:Kidney Tubules / Q000473:pathology; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D014019:Tissue Donors
D016853:Muromonab-CD3; D011239:Prednisolone